
Geistlich Bio-Gide® Forte: Trusted Technology with Advanced Handling
FOR IMMEDIATE RELEASE
PRINCETON, NJ — Geistlich is presenting Geistlich Bio-Gide® Forte, a new membrane based on proven collagen technology. It offers greater strength, is easy to handle, and adapts to the ridge contour. The resorbable membrane will be unveiled at the annual meeting of the American Academy of Periodontology (AAP).
Geistlich continuously expands its product portfolio to provide clinicians and patients worldwide with even more regenerative solutions. The family-owned company is launching Geistlich Bio-Gide® Forte, an advanced collagen membrane that supports reliable bone regeneration and optimal tissue integration. With its differentiated handling properties and high tensile strength, Geistlich Bio-Gide® Forte is designed for use in a wide range of bone and soft tissue regeneration cases.1,2
Proven Geistlich Bio-Gide® technology with added strength
Mark Spilker, Chief Science Officer at Geistlich, says: “With Geistlich Bio-Gide® Forte, we are expanding our membrane portfolio by offering a version of Geistlich Bio-Gide® that delivers particularly robust handling.” Geistlich Bio-Gide® Forte is particularly firm and stable when hydrated. The membrane unfolds easily, can be cut even when hydrated, and enables tailoring to defect size and shape, providing precise adaptation and optimal coverage .1 Building on the excellent properties of Geistlich Bio-Gide® technology, the new product also helps to improve the survival rate of implants.3
“With Geistlich Bio-Gide® Forte, we are expanding our membrane portfolio by offering a version of Geistlich Bio-Gide® that delivers particularly robust handling.”
— Mark Spilker, Chief Science Officer, Geistlich Pharma AG
About Geistlich North America Inc.
With 175 years of regenerative expertise, Geistlich continues to set the global standard in oral regeneration. The company offers a comprehensive portfolio of clinically proven biomaterials, including the world-renowned Geistlich Bio-Oss® and a full line of allografts under the vallos® brand.
The resorbable collagen membrane Geistlich Bio-Gide® is now available in a compressed version for varied handling preferences. For soft-tissue regeneration, Geistlich Mucograft® and Geistlich Fibro-Gide® provide scientifically validated alternatives to autogenous grafts. GEM 21S®, a growth-factor-enhanced matrix, rounds out the portfolio with targeted support for wound healing and bone regeneration.
Geistlich’s legacy of scientific collaboration, product excellence, and clinical outcomes is what makes Geistlich Biomaterials Exactly Like No Other.
Media Contact:
Jamie Bratton
[email protected]
Geistlich Pharma North America Inc.
400 Alexander Park Drive, Suite 302
Princeton, NJ 08540 USA
Home Page:
Social Media
- Data on File, Usability Test 2025, Geistlich Pharma AG, Wolhusen, Switzerland.
- Dewilde F, Hindryckx M, Younes F, Bruyckere TD, Cosyn J. Clin. Implant Dent. Relat. Res. 2024.doi:10.1111/cid.13313 Epub ahead of print.
- Knofler W, Barth T, Graul R, Krampe D. International journal of implant dentistry 2016.;2:25.

